Cargando…

Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Novazzi, Federica, Baj, Andreina, Ferrante, Francesca Drago, Boutahar, Sara, Genoni, Angelo Paolo, Gasperina, Daniela Dalla, Maggi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238025/
https://www.ncbi.nlm.nih.gov/pubmed/35789899
http://dx.doi.org/10.1016/j.jcvp.2022.100097
_version_ 1784736934665388032
author Focosi, Daniele
Novazzi, Federica
Baj, Andreina
Ferrante, Francesca Drago
Boutahar, Sara
Genoni, Angelo Paolo
Gasperina, Daniela Dalla
Maggi, Fabrizio
author_facet Focosi, Daniele
Novazzi, Federica
Baj, Andreina
Ferrante, Francesca Drago
Boutahar, Sara
Genoni, Angelo Paolo
Gasperina, Daniela Dalla
Maggi, Fabrizio
author_sort Focosi, Daniele
collection PubMed
description
format Online
Article
Text
id pubmed-9238025
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Authors. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-92380252022-06-28 Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases Focosi, Daniele Novazzi, Federica Baj, Andreina Ferrante, Francesca Drago Boutahar, Sara Genoni, Angelo Paolo Gasperina, Daniela Dalla Maggi, Fabrizio J Clin Virol Plus Article The Authors. Published by Elsevier Ltd. 2022-08 2022-06-28 /pmc/articles/PMC9238025/ /pubmed/35789899 http://dx.doi.org/10.1016/j.jcvp.2022.100097 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Focosi, Daniele
Novazzi, Federica
Baj, Andreina
Ferrante, Francesca Drago
Boutahar, Sara
Genoni, Angelo Paolo
Gasperina, Daniela Dalla
Maggi, Fabrizio
Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
title Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
title_full Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
title_fullStr Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
title_full_unstemmed Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
title_short Sotrovimab-emergent resistance in SARS-CoV-2 Omicron: A series of three cases
title_sort sotrovimab-emergent resistance in sars-cov-2 omicron: a series of three cases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238025/
https://www.ncbi.nlm.nih.gov/pubmed/35789899
http://dx.doi.org/10.1016/j.jcvp.2022.100097
work_keys_str_mv AT focosidaniele sotrovimabemergentresistanceinsarscov2omicronaseriesofthreecases
AT novazzifederica sotrovimabemergentresistanceinsarscov2omicronaseriesofthreecases
AT bajandreina sotrovimabemergentresistanceinsarscov2omicronaseriesofthreecases
AT ferrantefrancescadrago sotrovimabemergentresistanceinsarscov2omicronaseriesofthreecases
AT boutaharsara sotrovimabemergentresistanceinsarscov2omicronaseriesofthreecases
AT genoniangelopaolo sotrovimabemergentresistanceinsarscov2omicronaseriesofthreecases
AT gasperinadanieladalla sotrovimabemergentresistanceinsarscov2omicronaseriesofthreecases
AT maggifabrizio sotrovimabemergentresistanceinsarscov2omicronaseriesofthreecases